Jeffrey David Benner (Jeffrey D Benner)

Years Active: 2019-2024
Publications (10 Years): 5

Retina Consultants of Delamarva

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Retina Consultants of Delamarva

United States

Partner nad founder

Publications

Robert L Joyner, Joseph A Hollenbaugh, Donald D'Aquila, Marc Fishman, Steven M Cohen, Veera Holdai, Jeffrey David Benner
Bioabsorbable, subcutaneous naltrexone implants mitigate fentanyl-induced respiratory depression at 3 months-A pilot study in male canines. Physiological reports 12 (15) (2024)
Robert L Joyner, Joseph A Hollenbaugh, Donald D'Aquila, Marc Fishman, Steven M Cohen, Veera Holdai, Jeffrey David Benner
Bioabsorbable, subcutaneous naltrexone implants mitigate fentanyl-induced respiratory depression at 3 months-A pilot study in male canines. Physiological reports 12 (15) (2024)
Robert L Joyner, Joseph A Hollenbaugh, Donald D'Aquila, Marc Fishman, Steven M Cohen, Veera Holdai, Jeffrey David Benner
Bioabsorbable, subcutaneous naltrexone implants mitigate fentanyl-induced respiratory depression at 3 months-A pilot study in male canines. Physiological reports 12 (15) (2024)
Jeffrey David Benner, Steven M Cohen, Joseph A Hollenbaugh, Marc Fishman
Fentanyl-induced respiratory depression in rodents is inhibited by bioabsorbable, subcutaneous naltrexone implants at 3.5 months. Addiction biology 28 (12) (2023)
Jeffrey David Benner, David Dao, John W Butler, Kelli I Hamill
Intravitreal methotrexate for the treatment of proliferative vitreoretinopathy. BMJ open ophthalmology 4 (1) (2019)

Jeffrey David Benner.css-eqlu8i{font-size:small;padding-left:4px;} (Jeffrey D Benner)